Literature DB >> 1844365

[Bacterial overgrowth in small intestine in patients with liver cirrhosis].

J Chesta1, M Silva, L Thompson, E del Canto, C Defilippi.   

Abstract

Hepatic encephalopathy, bacterial infections and endotoxemia in cirrhotic patients have been related to colonic flora. However, an abnormal small bowel bacterial content could also be implied. We investigated small bowel bacterial overgrowth (SIBO) by jejunal cultures in 14 cirrhotic patients and 5 control subjects, and indirectly by the lactulose H2 breath test in 22 patients with cirrhosis and 12 controls. SIBO was demonstrated by cultures in 64% of cirrhotic patients and 1 of 5 controls. The breath test was positive for SIBO in 45% of patients with cirrhosis and 8% of controls. No differences were noted between patients with alcoholic and non-alcoholic liver disease. According to fasting H2 breath levels, SIBO was significantly correlated with the Child-Pugh score for hepatic function (r = 0.45; p < 0.05). Also, patients with positive criteria for SIBO in jejunal cultures had worse hepatic function in comparison to cirrhotics with normal jejunal bacterial counts (p < 0.05). Thus SIBO is frequent in patients with hepatic cirrhosis and is associated with impairment in hepatic function.

Entities:  

Mesh:

Year:  1991        PMID: 1844365

Source DB:  PubMed          Journal:  Rev Med Chil        ISSN: 0034-9887            Impact factor:   0.553


  10 in total

1.  Small intestinal bacterial overgrowth in patients with morbid obesity.

Authors:  Pauline Jouet; Benoit Coffin; Jean-Marc Sabate
Journal:  Dig Dis Sci       Date:  2011-02       Impact factor: 3.199

2.  Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients.

Authors:  Haifeng Lu; Zhongwen Wu; Wei Xu; Jiezuan Yang; Yunbo Chen; Lanjuan Li
Journal:  Microb Ecol       Date:  2011-02-01       Impact factor: 4.552

3.  The role of the gut microbiota in nonalcoholic fatty liver disease.

Authors:  Ahmed Abu-Shanab; Eamonn M M Quigley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-02       Impact factor: 46.802

Review 4.  Small Intestinal Bacterial Overgrowth in Patients With Cirrhosis.

Authors:  Gaurav Ghosh; Arun B Jesudian
Journal:  J Clin Exp Hepatol       Date:  2018-08-27

Review 5.  Gastrointestinal dysfunction in liver disease and portal hypertension. Gut-liver interactions revisited.

Authors:  E M Quigley
Journal:  Dig Dis Sci       Date:  1996-03       Impact factor: 3.199

6.  Hepatotoxic agent thioacetamide induces biochemical and histological alterations in rat small intestine.

Authors:  M A Ortega; M I Torres; M I Fernández; A Rios; A Sánchez-Pozo; A Gil
Journal:  Dig Dis Sci       Date:  1997-08       Impact factor: 3.199

7.  Altered small bowel motility in patients with liver cirrhosis depends on severity of liver disease.

Authors:  A M Madrid; F Cumsille; C Defilippi
Journal:  Dig Dis Sci       Date:  1997-04       Impact factor: 3.199

8.  Small intestinal bacterial overgrowth in cirrhosis: systematic review and meta-analysis.

Authors:  Roman Maslennikov; Chavdar Pavlov; Vladimir Ivashkin
Journal:  Hepatol Int       Date:  2018-10-04       Impact factor: 6.047

9.  Frequency and factors associated with small intestinal bacterial overgrowth in patients with cirrhosis of the liver and extra hepatic portal venous obstruction.

Authors:  C P Lakshmi; Uday C Ghoshal; Sunil Kumar; Amit Goel; Asha Misra; Samir Mohindra; G Choudhuri
Journal:  Dig Dis Sci       Date:  2009-05-08       Impact factor: 3.199

10.  Influence of proton pump inhibitors in the development of spontaneous bacterial peritonitis.

Authors:  Suelen A S Miozzo; Jorge A John; Marcelo C Appel-da-Silva; Isabella A Dossin; Cristiane V Tovo; Angelo A Mattos
Journal:  World J Hepatol       Date:  2017-12-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.